Cargando…

Ventricular Tachycardia Triggered by Loperamide and Famotidine Abuse

A 32-year-old male developed recurrent ventricular tachycardia after taking mega doses of loperamide and famotidine in order to experience an opiate-like euphoric effect. He was taking up to 200 mg of loperamide and multiple doses of famotidine each day. He developed palpitations and syncope. Electr...

Descripción completa

Detalles Bibliográficos
Autores principales: Larsen, Timothy R., McMunn, Jedediah, Ahmad, Hala, AlMahameed, Soufian T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816737/
https://www.ncbi.nlm.nih.gov/pubmed/29455270
http://dx.doi.org/10.1007/s40800-018-0077-0
_version_ 1783300734726438912
author Larsen, Timothy R.
McMunn, Jedediah
Ahmad, Hala
AlMahameed, Soufian T.
author_facet Larsen, Timothy R.
McMunn, Jedediah
Ahmad, Hala
AlMahameed, Soufian T.
author_sort Larsen, Timothy R.
collection PubMed
description A 32-year-old male developed recurrent ventricular tachycardia after taking mega doses of loperamide and famotidine in order to experience an opiate-like euphoric effect. He was taking up to 200 mg of loperamide and multiple doses of famotidine each day. He developed palpitations and syncope. Electrocardiography demonstrated ventricular tachycardia and QT interval prolongation (corrected QT interval was 597 ms). He was diagnosed with loperamide-induced QT prolongation resulting in incessant ventricular tachycardia. Loperamide was discontinued, and he was treated with electrolyte replacement, supportive care, and monitoring. After 5 days, his electrocardiogram (ECG) normalized and he had no more ventricular tachycardia. A Naranjo assessment score of 8 was obtained, indicating a probable relationship between QT prolongation and his use of loperamide. Large doses of loperamide can cause QT interval prolongation and life-threatening arrhythmias. These effects may be accentuated when histamine-2 receptor blockers are also abused.
format Online
Article
Text
id pubmed-5816737
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-58167372018-02-27 Ventricular Tachycardia Triggered by Loperamide and Famotidine Abuse Larsen, Timothy R. McMunn, Jedediah Ahmad, Hala AlMahameed, Soufian T. Drug Saf Case Rep Case Report A 32-year-old male developed recurrent ventricular tachycardia after taking mega doses of loperamide and famotidine in order to experience an opiate-like euphoric effect. He was taking up to 200 mg of loperamide and multiple doses of famotidine each day. He developed palpitations and syncope. Electrocardiography demonstrated ventricular tachycardia and QT interval prolongation (corrected QT interval was 597 ms). He was diagnosed with loperamide-induced QT prolongation resulting in incessant ventricular tachycardia. Loperamide was discontinued, and he was treated with electrolyte replacement, supportive care, and monitoring. After 5 days, his electrocardiogram (ECG) normalized and he had no more ventricular tachycardia. A Naranjo assessment score of 8 was obtained, indicating a probable relationship between QT prolongation and his use of loperamide. Large doses of loperamide can cause QT interval prolongation and life-threatening arrhythmias. These effects may be accentuated when histamine-2 receptor blockers are also abused. Springer International Publishing 2018-02-17 /pmc/articles/PMC5816737/ /pubmed/29455270 http://dx.doi.org/10.1007/s40800-018-0077-0 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Case Report
Larsen, Timothy R.
McMunn, Jedediah
Ahmad, Hala
AlMahameed, Soufian T.
Ventricular Tachycardia Triggered by Loperamide and Famotidine Abuse
title Ventricular Tachycardia Triggered by Loperamide and Famotidine Abuse
title_full Ventricular Tachycardia Triggered by Loperamide and Famotidine Abuse
title_fullStr Ventricular Tachycardia Triggered by Loperamide and Famotidine Abuse
title_full_unstemmed Ventricular Tachycardia Triggered by Loperamide and Famotidine Abuse
title_short Ventricular Tachycardia Triggered by Loperamide and Famotidine Abuse
title_sort ventricular tachycardia triggered by loperamide and famotidine abuse
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816737/
https://www.ncbi.nlm.nih.gov/pubmed/29455270
http://dx.doi.org/10.1007/s40800-018-0077-0
work_keys_str_mv AT larsentimothyr ventriculartachycardiatriggeredbyloperamideandfamotidineabuse
AT mcmunnjedediah ventriculartachycardiatriggeredbyloperamideandfamotidineabuse
AT ahmadhala ventriculartachycardiatriggeredbyloperamideandfamotidineabuse
AT almahameedsoufiant ventriculartachycardiatriggeredbyloperamideandfamotidineabuse